© 2026 Public Radio Tulsa
800 South Tucker Drive
Tulsa, OK 74104
(918) 631-2577

A listener-supported service of The University of Tulsa
classical 88.7 | public radio 89.5
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

New mRNA vaccine could reduce the recurrence and spread of skin cancer

NPR | By Leila Fadel
Published August 20, 2026 at 3:45 AM CDT

Merck and Moderna announced a successful late-stage trial for a melanoma vaccine. NPR's Leila Fadel talks to Dr. Robert Vonderheide of Penn Medicine and the American Association for Cancer Research.

Copyright 2026 NPR
Leila Fadel
Leila Fadel is a host of Morning Edition, as well as NPR's morning news podcast Up First.